vaccinex.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | Vaccinex | Science in the service of |
| Description | FEATURED × CLOSE Home About Corporate Overview Management Partners Pipeline Pepinemab Neurology Pepinemab Immuno-Oncology Research & Development Programs Clinical |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.46.88.224 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
vaccinex.com Valuation
|
US$13,044,222
Last updated: 2023-05-08 21:53:17
vaccinex.com has Semrush global rank of 811,417. vaccinex.com has an estimated worth of US$ 13,044,222, based on its estimated Ads revenue. vaccinex.com receives approximately 1,505,103 unique visitors each day. Its web server is located in United States, with IP address 198.46.88.224. According to SiteAdvisor, vaccinex.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$13,044,222 |
| Daily Ads Revenue | US$12,041 |
| Monthly Ads Revenue | US$361,225 |
| Yearly Ads Revenue | US$4,334,696 |
| Daily Unique Visitors | 100,341 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| vaccinex.com. | A | 3599 | IP: 198.46.88.224 |
| vaccinex.com. | NS | 3600 | NS Record: ns14.domaincontrol.com. |
| vaccinex.com. | NS | 3600 | NS Record: ns13.domaincontrol.com. |
| vaccinex.com. | MX | 3600 | MX Record: 0 VACCINEX-COM.mail.protection.outlook.com. |
| vaccinex.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-08 21:53:17
| × CLOSE Home About Corporate Overview Management Partners Pipeline Pepinemab Neurology Pepinemab Immuno-Oncology Research & Development Programs Clinical Trials Neurology Oncology ActivMAb ® Vaccinia Antibody Discovery Antigen Virus Protein Optimization Antigen Discovery Antibody Optimization ActivMAb ® Contact News & Publications News Publications Investors Investor Overview News Releases Events Presentations Stock Information Corporate Governance Financial Information Investor Services Events Presentations Careers Contact Us --> Science in the service of medicine About Corporate Overview Management Partners Pipeline Pepinemab Neurology Pepinemab Immuno-Oncology Research & Development Programs Clinical Trials Neurology Oncology ActivMAb ® Vaccinia Antibody Discovery Antigen Virus Protein Optimization Antigen Discovery Antibody Optimization Contact Us News & Publications News Publications Investors Investor Overview News Releases Events Presentations Stock Information Corporate |
HTTP Headers
HTTP/1.1 406 Not Acceptable Server: nginx/1.21.3 Date: Sat, 30 Oct 2021 18:26:27 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 300 Connection: keep-alive |
vaccinex.com Whois Information
Domain Name: VACCINEX.COM Registry Domain ID: 2325683_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2016-10-28T15:20:40Z Creation Date: 1998-11-02T05:00:00Z Registry Expiry Date: 2021-11-01T04:00:00Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS13.DOMAINCONTROL.COM Name Server: NS14.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T04:45:57Z <<< |